| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | 4.543 | 5.333 | 7.672 | 6.870 | 20.177 | 2.871 | 0 | 94.067 | 9.629 |
| Total Income - EUR | - | 4.543 | 5.333 | 7.672 | 6.870 | 20.177 | 2.876 | 0 | 94.067 | 9.629 |
| Total Expenses - EUR | - | 175 | 50 | 77 | 205 | 77 | 70 | 110 | 69 | 168 |
| Gross Profit/Loss - EUR | - | 4.368 | 5.283 | 7.594 | 6.665 | 20.101 | 2.806 | -110 | 93.998 | 9.461 |
| Net Profit/Loss - EUR | - | 4.232 | 5.122 | 7.372 | 6.471 | 19.547 | 2.721 | -110 | 78.958 | 7.996 |
| Employees | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Expert Medfiz Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | 163 | 160 | 158 | 154 | 152 | 148 | 149 | 148 | 147 |
| Current Assets | - | 4.650 | 9.720 | 16.814 | 22.943 | 21.343 | 23.590 | 23.200 | 95.692 | 90.209 |
| Inventories | - | 41 | 40 | 40 | 39 | 38 | 37 | 38 | 37 | 37 |
| Receivables | - | 668 | 79 | 16.774 | 0 | 229 | 268 | 0 | 81.350 | 0 |
| Cash | - | 3.941 | 9.601 | 0 | 22.904 | 21.075 | 23.285 | 23.162 | 14.304 | 90.172 |
| Shareholders Funds | - | 4.276 | 9.326 | 16.527 | 22.678 | 21.122 | 23.375 | 3.059 | 82.008 | 9.132 |
| Social Capital | - | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | 537 | 554 | 444 | 419 | 372 | 364 | 20.289 | 13.833 | 81.225 |
| Income in Advance | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8699 - 8699" | |||||||||
| CAEN Financial Year |
8690
|
|||||||||
Comments - Expert Medfiz Srl